Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 9 studies | 32% ± 14% | |
| oligodendrocyte precursor cell | 9 studies | 39% ± 16% | |
| microglial cell | 7 studies | 28% ± 9% | |
| glutamatergic neuron | 6 studies | 41% ± 21% | |
| endothelial cell | 5 studies | 25% ± 7% | |
| epithelial cell | 5 studies | 22% ± 5% | |
| GABAergic neuron | 4 studies | 46% ± 10% | |
| fibroblast | 4 studies | 19% ± 4% | |
| abnormal cell | 3 studies | 21% ± 2% | |
| neuron | 3 studies | 31% ± 5% | |
| interneuron | 3 studies | 40% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 10 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3545.24 | 2642 / 2642 | 100% | 39.19 | 705 / 705 |
| thymus | 100% | 1775.34 | 652 / 653 | 100% | 29.48 | 602 / 605 |
| skin | 100% | 3315.73 | 1804 / 1809 | 98% | 29.24 | 461 / 472 |
| esophagus | 100% | 1950.08 | 1444 / 1445 | 97% | 13.62 | 177 / 183 |
| lung | 99% | 2000.31 | 575 / 578 | 96% | 11.98 | 1110 / 1155 |
| kidney | 100% | 1592.96 | 89 / 89 | 95% | 18.72 | 860 / 901 |
| breast | 100% | 1565.97 | 458 / 459 | 94% | 12.07 | 1051 / 1118 |
| pancreas | 96% | 1061.42 | 314 / 328 | 97% | 10.66 | 172 / 178 |
| adrenal gland | 100% | 2408.46 | 258 / 258 | 91% | 12.92 | 210 / 230 |
| stomach | 99% | 1243.39 | 354 / 359 | 89% | 11.05 | 254 / 286 |
| uterus | 100% | 2172.06 | 170 / 170 | 86% | 9.22 | 395 / 459 |
| prostate | 100% | 2076.17 | 245 / 245 | 85% | 6.97 | 426 / 502 |
| intestine | 100% | 1905.61 | 966 / 966 | 82% | 8.18 | 430 / 527 |
| bladder | 100% | 1871.00 | 21 / 21 | 81% | 8.11 | 406 / 504 |
| liver | 96% | 1196.24 | 218 / 226 | 71% | 6.15 | 287 / 406 |
| ovary | 97% | 1195.23 | 174 / 180 | 67% | 5.30 | 289 / 430 |
| blood vessel | 100% | 3125.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 19.25 | 29 / 29 |
| spleen | 100% | 1739.79 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1672.78 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 1488.16 | 840 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 12.22 | 42 / 45 |
| eye | 0% | 0 | 0 / 0 | 93% | 19.28 | 74 / 80 |
| muscle | 89% | 780.20 | 718 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 68% | 3145.43 | 631 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0006974 | Biological process | DNA damage response |
| GO_0015031 | Biological process | protein transport |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | ZMAT3 |
| Protein name | Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein) Zinc finger matrin-type 3 |
| Synonyms | WIG1 PAG608 |
| Description | FUNCTION: Acts as a bona fide target gene of p53/TP53. May play a role in the TP53-dependent growth regulatory pathway. May contribute to TP53-mediated apoptosis by regulation of TP53 expression and translocation to the nucleus and nucleolus. . |
| Accessions | ENST00000311417.7 [Q9HA38-1] C9J8H5 ENST00000652290.1 Q9HA38 ENST00000414084.1 ENST00000432729.5 [Q9HA38-2] A0A494C120 |
